|
US4179337A
(en)
|
1973-07-20 |
1979-12-18 |
Davis Frank F |
Non-immunogenic polypeptides
|
|
US4657760A
(en)
|
1979-03-20 |
1987-04-14 |
Ortho Pharmaceutical Corporation |
Methods and compositions using monoclonal antibody to human T cells
|
|
JPS6023084B2
(ja)
|
1979-07-11 |
1985-06-05 |
味の素株式会社 |
代用血液
|
|
US4399216A
(en)
|
1980-02-25 |
1983-08-16 |
The Trustees Of Columbia University |
Processes for inserting DNA into eucaryotic cells and for producing proteinaceous materials
|
|
ZA811368B
(en)
|
1980-03-24 |
1982-04-28 |
Genentech Inc |
Bacterial polypedtide expression employing tryptophan promoter-operator
|
|
NZ201705A
(en)
|
1981-08-31 |
1986-03-14 |
Genentech Inc |
Recombinant dna method for production of hepatitis b surface antigen in yeast
|
|
US4640835A
(en)
|
1981-10-30 |
1987-02-03 |
Nippon Chemiphar Company, Ltd. |
Plasminogen activator derivatives
|
|
US4943529A
(en)
|
1982-05-19 |
1990-07-24 |
Gist-Brocades Nv |
Kluyveromyces as a host strain
|
|
AU2353384A
(en)
|
1983-01-19 |
1984-07-26 |
Genentech Inc. |
Amplification in eukaryotic host cells
|
|
US4713339A
(en)
|
1983-01-19 |
1987-12-15 |
Genentech, Inc. |
Polycistronic expression vector construction
|
|
AU3145184A
(en)
|
1983-08-16 |
1985-02-21 |
Zymogenetics Inc. |
High expression of foreign genes in schizosaccharomyces pombe
|
|
US4496689A
(en)
|
1983-12-27 |
1985-01-29 |
Miles Laboratories, Inc. |
Covalently attached complex of alpha-1-proteinase inhibitor with a water soluble polymer
|
|
US4879231A
(en)
|
1984-10-30 |
1989-11-07 |
Phillips Petroleum Company |
Transformation of yeasts of the genus pichia
|
|
US4683202A
(en)
|
1985-03-28 |
1987-07-28 |
Cetus Corporation |
Process for amplifying nucleic acid sequences
|
|
US4683195A
(en)
|
1986-01-30 |
1987-07-28 |
Cetus Corporation |
Process for amplifying, detecting, and/or-cloning nucleic acid sequences
|
|
US4965188A
(en)
|
1986-08-22 |
1990-10-23 |
Cetus Corporation |
Process for amplifying, detecting, and/or cloning nucleic acid sequences using a thermostable enzyme
|
|
EP0206448B1
(en)
|
1985-06-19 |
1990-11-14 |
Ajinomoto Co., Inc. |
Hemoglobin combined with a poly(alkylene oxide)
|
|
US5206344A
(en)
|
1985-06-26 |
1993-04-27 |
Cetus Oncology Corporation |
Interleukin-2 muteins and polymer conjugation thereof
|
|
WO1987005330A1
(en)
|
1986-03-07 |
1987-09-11 |
Michel Louis Eugene Bergh |
Method for enhancing glycoprotein stability
|
|
US4849227A
(en)
|
1986-03-21 |
1989-07-18 |
Eurasiam Laboratories, Inc. |
Pharmaceutical compositions
|
|
GB8610600D0
(en)
|
1986-04-30 |
1986-06-04 |
Novo Industri As |
Transformation of trichoderma
|
|
US4791192A
(en)
|
1986-06-26 |
1988-12-13 |
Takeda Chemical Industries, Ltd. |
Chemically modified protein with polyethyleneglycol
|
|
IL85035A0
(en)
|
1987-01-08 |
1988-06-30 |
Int Genetic Eng |
Polynucleotide molecule,a chimeric antibody with specificity for human b cell surface antigen,a process for the preparation and methods utilizing the same
|
|
WO1988007089A1
(en)
|
1987-03-18 |
1988-09-22 |
Medical Research Council |
Altered antibodies
|
|
US5010182A
(en)
|
1987-07-28 |
1991-04-23 |
Chiron Corporation |
DNA constructs containing a Kluyveromyces alpha factor leader sequence for directing secretion of heterologous polypeptides
|
|
DE3889546T2
(de)
|
1987-12-21 |
1994-09-08 |
Univ Toledo |
Transformation von keimenden pflanzensamen mit hilfe von agrobacterium.
|
|
AU4005289A
(en)
|
1988-08-25 |
1990-03-01 |
Smithkline Beecham Corporation |
Recombinant saccharomyces
|
|
US5225538A
(en)
|
1989-02-23 |
1993-07-06 |
Genentech, Inc. |
Lymphocyte homing receptor/immunoglobulin fusion proteins
|
|
ATE144281T1
(de)
|
1989-04-28 |
1996-11-15 |
Rhein Biotech Proz & Prod Gmbh |
Hefezellen der gattung-schwanniomyces
|
|
EP0402226A1
(en)
|
1989-06-06 |
1990-12-12 |
Institut National De La Recherche Agronomique |
Transformation vectors for yeast yarrowia
|
|
FR2649120B1
(fr)
|
1989-06-30 |
1994-01-28 |
Cayla |
Nouvelle souche et ses mutants de champignons filamenteux, procede de production de proteines recombinantes a l'aide de ladite souche et souches et proteines obtenues selon ce procede
|
|
US5225212A
(en)
|
1989-10-20 |
1993-07-06 |
Liposome Technology, Inc. |
Microreservoir liposome composition and method
|
|
WO1992022653A1
(en)
|
1991-06-14 |
1992-12-23 |
Genentech, Inc. |
Method for making humanized antibodies
|
|
DE69325029T2
(de)
|
1992-10-01 |
1999-10-07 |
Schering Corp., Kenilworth |
Verwendung der il-10 zur verhinderung des insulin-abhängigen diabetes mellitus
|
|
EP1013270A3
(en)
|
1992-12-02 |
2001-03-28 |
Alkermes Controlled Therapeutics, Inc. |
Controlled release growth hormone containing microspheres
|
|
CA2163345A1
(en)
|
1993-06-16 |
1994-12-22 |
Susan Adrienne Morgan |
Antibodies
|
|
US5951974A
(en)
|
1993-11-10 |
1999-09-14 |
Enzon, Inc. |
Interferon polymer conjugates
|
|
US5446090A
(en)
|
1993-11-12 |
1995-08-29 |
Shearwater Polymers, Inc. |
Isolatable, water soluble, and hydrolytically stable active sulfones of poly(ethylene glycol) and related polymers for modification of surfaces and molecules
|
|
AU1684195A
(en)
|
1994-02-22 |
1995-09-04 |
Georgia Tech Research Corporation |
Reduction of friction during wire drawing
|
|
EP0779806B2
(en)
|
1994-09-09 |
2008-04-16 |
Takeda Pharmaceutical Company Limited |
Sustained release preparation containing metal salt of a peptide
|
|
EP0739981A1
(en)
|
1995-04-25 |
1996-10-30 |
Vrije Universiteit Brussel |
Variable fragments of immunoglobulins - use for therapeutic or veterinary purposes
|
|
DK0831787T3
(da)
|
1995-06-07 |
2001-12-17 |
Alkermes Inc |
Sammensætning til vedvarende frigivelse af humant væksthormon
|
|
ZA965368B
(en)
|
1995-07-14 |
1997-01-14 |
Novo Nordisk As |
A pharmaceutical formulation
|
|
IL131126A
(en)
|
1997-02-21 |
2003-04-10 |
Abbott Lab |
Compositions for reducing the incidence of necrotizing enterocolitis and the preparation thereof
|
|
US6551799B2
(en)
|
1999-12-07 |
2003-04-22 |
Genentech, Inc. |
Interleukin-22 polypeptides, nucleic acids encoding the same and methods for the treatment of pancreatic disorders
|
|
DE69937291T2
(de)
|
1998-04-02 |
2008-07-10 |
Genentech, Inc., South San Francisco |
Antikörpervarianten und fragmente davon
|
|
US6194551B1
(en)
|
1998-04-02 |
2001-02-27 |
Genentech, Inc. |
Polypeptide variants
|
|
NZ507381A
(en)
|
1998-04-21 |
2003-12-19 |
Micromet Ag |
CD19xCD3 specific polypeptides and uses thereof
|
|
US20030003545A1
(en)
|
1998-05-29 |
2003-01-02 |
Reinhard Ebner |
Interleukins-21 and 22
|
|
US20010023070A1
(en)
|
1998-05-29 |
2001-09-20 |
Reinhard Ebner |
Interleukins-21 and 22
|
|
US6274710B1
(en)
|
1998-10-26 |
2001-08-14 |
Ludwig Institute For Cancer Research |
Antibodies which specifically bind T Cell inducible factors (TIFs)
|
|
CN1238367C
(zh)
|
1998-10-26 |
2006-01-25 |
路德维格癌症研究院 |
分离的编码t细胞诱导因子(tif)的核酸分子,其编码蛋白及其应用
|
|
KR20060067983A
(ko)
|
1999-01-15 |
2006-06-20 |
제넨테크, 인크. |
효과기 기능이 변화된 폴리펩티드 변이체
|
|
US6737056B1
(en)
|
1999-01-15 |
2004-05-18 |
Genentech, Inc. |
Polypeptide variants with altered effector function
|
|
US7307161B1
(en)
|
1999-04-28 |
2007-12-11 |
Genetics Institute, Llc |
Human Gil-19/AE289 polynucleotides
|
|
US7226591B2
(en)
|
2000-05-22 |
2007-06-05 |
Genentech, Inc. |
Interleukin-22 polypeptides, nucleic acids encoding the same and methods for the treatment of pancreatic disorders
|
|
CN1163263C
(zh)
|
2000-01-07 |
2004-08-25 |
华中理工大学 |
一种多肽类药物口腔喷雾剂
|
|
GB0024442D0
(en)
|
2000-10-05 |
2000-11-22 |
Isis Innovation |
Genetic factors affecting the outcome of viral infections
|
|
CN1335182A
(zh)
|
2001-08-08 |
2002-02-13 |
华中科技大学 |
胰岛素口腔喷剂及其制备工艺
|
|
US6797493B2
(en)
|
2001-10-01 |
2004-09-28 |
Lee-Hwei K. Sun |
Fc fusion proteins of human granulocyte colony-stimulating factor with increased biological activities
|
|
MXPA04004266A
(es)
|
2001-11-06 |
2004-07-08 |
Lilly Co Eli |
Uso de il-19, il-22 e il-24 para tratar trastornos hematopoyeticos.
|
|
EP1463752A4
(en)
|
2001-12-21 |
2005-07-13 |
Human Genome Sciences Inc |
ALBUMIN FUSION PROTEINS
|
|
CN1176137C
(zh)
|
2002-01-15 |
2004-11-17 |
泛亚生物技术有限公司 |
多臂树杈型功能化聚乙二醇制备方法及它在药物中的应用
|
|
EP1499328B1
(en)
|
2002-04-15 |
2015-09-16 |
University of Pittsburgh - Of the Commonwealth System of Higher Education |
Methods of treating necrotizing enterocolitis
|
|
US7597876B2
(en)
|
2007-01-11 |
2009-10-06 |
Immunomedics, Inc. |
Methods and compositions for improved F-18 labeling of proteins, peptides and other molecules
|
|
US20030235561A1
(en)
|
2002-06-25 |
2003-12-25 |
Cell Based Delivery Inc. |
Vascularized organized tissues and uses thereof
|
|
US7361740B2
(en)
|
2002-10-15 |
2008-04-22 |
Pdl Biopharma, Inc. |
Alteration of FcRn binding affinities or serum half-lives of antibodies by mutagenesis
|
|
PT1572744E
(pt)
|
2002-12-16 |
2010-09-07 |
Genentech Inc |
Variantes de imunoglobulina e utilizações destas
|
|
US20050148029A1
(en)
|
2003-09-29 |
2005-07-07 |
Biosite, Inc. |
Methods and compositions for determining treatment regimens in systemic inflammatory response syndromes
|
|
BRPI0416240A
(pt)
|
2003-11-05 |
2007-01-09 |
Inst Rech Developpement Ird |
usos de um ou vários agonistas de famìlia de receptores de receptores de formil peptìdeo e semelhante a receptores de formil peptìdeo, composições farmecêuticas para evitar ou tratar infecções virais ou retro-virais, e, método para favorecer a resistência inata de hospedeiros a infecções virais
|
|
BRPI0507680A
(pt)
|
2004-02-13 |
2007-07-17 |
Nod Pharmaceuticals Inc |
partìculas de fosfato de cálcio terapêuticas e métodos de fabricação e uso das mesmas
|
|
EP2360186B1
(en)
|
2004-04-13 |
2017-08-30 |
F. Hoffmann-La Roche AG |
Anti-P-selectin antibodies
|
|
US7670595B2
(en)
|
2004-06-28 |
2010-03-02 |
Merck Patent Gmbh |
Fc-interferon-beta fusion proteins
|
|
TWI380996B
(zh)
|
2004-09-17 |
2013-01-01 |
Hoffmann La Roche |
抗ｏｘ４０ｌ抗體
|
|
CN100515491C
(zh)
|
2005-01-04 |
2009-07-22 |
健能隆医药技术（上海）有限公司 |
白介素-22的医药用途
|
|
EP2322553A3
(en)
|
2005-02-14 |
2011-11-16 |
Wyeth LLC |
Interleukin-17F antibodies and other IL-17F signaling antagonists and uses therefor
|
|
AU2006304605A1
(en)
|
2005-10-17 |
2007-04-26 |
Institute For Systems Biology |
Tissue-and serum-derived glycoproteins and methods of their use
|
|
UA95613C2
(ru)
|
2005-11-09 |
2011-08-25 |
Уеллстат Терепьютикс Корпорейшн |
Соединения для лечения расстройсв метаболизма
|
|
WO2007115230A2
(en)
*
|
2006-03-30 |
2007-10-11 |
University Of Medicine And Dentistry Of New Jersey |
A strategy for homo- or hetero-dimerization of various proteins in solutions and in cells
|
|
WO2007123765A2
(en)
|
2006-03-31 |
2007-11-01 |
Human Genome Sciences Inc. |
Neutrokine-alpha and neutrokine-alpha splice variant
|
|
CN101472611A
(zh)
|
2006-06-19 |
2009-07-01 |
惠氏公司 |
调节il-22和il-17的方法
|
|
WO2008085229A2
(en)
|
2006-11-15 |
2008-07-17 |
Arteriocyte Inc. |
Cell-based therapies for treating liver disease
|
|
CN101361968B
(zh)
|
2007-08-06 |
2011-08-03 |
健能隆医药技术（上海）有限公司 |
白介素-22在治疗脂肪肝中的应用
|
|
WO2009041734A1
(ja)
|
2007-09-26 |
2009-04-02 |
Kyowa Hakko Kirin Co., Ltd. |
ヒトトロンボポエチン受容体に対するアゴニスト抗体
|
|
EP2207429B2
(en)
|
2007-10-09 |
2016-12-28 |
Enzymotec Ltd. |
Lipid compositions for the treatment of gastro-intestinal disorders
|
|
CN101168049A
(zh)
|
2007-10-23 |
2008-04-30 |
中国人民解放军军事医学科学院基础医学研究所 |
白介素-22在制备治疗肝病药物中的应用及其制备方法
|
|
CN101225110B
(zh)
|
2007-10-23 |
2010-10-20 |
中国人民解放军军事医学科学院基础医学研究所 |
人白细胞介素-22突变体及其构建方法和应用
|
|
AU2008323770B2
(en)
|
2007-11-07 |
2014-08-07 |
Genentech, Inc. |
Compositions and methods for treatment of microbial disorders
|
|
CN102124344B
(zh)
|
2008-05-16 |
2015-04-01 |
霍夫曼-拉罗奇有限公司 |
生物标记用于评估β7整联蛋白拮抗剂治疗胃肠道炎性病症的用途
|
|
US8178051B2
(en)
|
2008-11-05 |
2012-05-15 |
Stephen Michael Lord |
Apparatus and process for hydrogenation of a silicon tetrahalide and silicon to the trihalosilane
|
|
US8956605B2
(en)
|
2009-01-12 |
2015-02-17 |
Generon (Shanghai) Corporation |
Prevention and/or treatment of multiple organ dysfunction syndrome with interleukin-22
|
|
US20130121959A1
(en)
|
2010-01-13 |
2013-05-16 |
Joseph R. Maxwell |
Il-22-fc and hepcidin activity
|
|
CN102380091A
(zh)
*
|
2010-08-31 |
2012-03-21 |
健能隆医药技术（上海）有限公司 |
白介素-22在治疗病毒性肝炎中的应用
|
|
CN103182072B
(zh)
*
|
2011-12-27 |
2017-05-03 |
健能隆医药技术（上海）有限公司 |
白介素‑22在治疗和预防神经损伤疾病或神经退行性疾病中的用途
|
|
DK2970422T3
(da)
|
2013-03-15 |
2018-07-16 |
Hoffmann La Roche |
Il-22-polypeptider og il-22 fc-fusionsproteiner og fremgangsmåder til anvendelse
|
|
CN106029100A
(zh)
|
2013-11-07 |
2016-10-12 |
纪念斯隆–凯特林癌病中心 |
在胃肠道移植物抗宿主病的治疗中使用il-22的方法
|
|
CN104623637A
(zh)
|
2013-11-07 |
2015-05-20 |
健能隆医药技术（上海）有限公司 |
Il-22二聚体在制备静脉注射药物中的应用
|
|
CN104623639A
(zh)
|
2013-11-07 |
2015-05-20 |
健能隆医药技术（上海）有限公司 |
白介素22二聚体在制备治疗胰腺炎药物中的应用
|
|
EP3160964B1
(en)
|
2014-06-27 |
2024-03-13 |
Nogra Pharma Limited |
Aryl receptor modulators and methods of making and using the same
|
|
MA41020A
(fr)
|
2014-11-25 |
2017-10-03 |
Evelo Biosciences Inc |
Compositions probiotiques et prébiotiques, et leurs procédés d'utilisation pour la modulation du microbiome
|
|
WO2017181143A1
(en)
|
2016-04-15 |
2017-10-19 |
Generon (Shanghai) Corporation, Ltd. |
Use of il-22 in treating necrotizing enterocolitis
|
|
KR20200125590A
(ko)
|
2018-01-26 |
2020-11-04 |
제넨테크, 인크. |
조성물 및 사용 방법
|
|
SG11202007694UA
(en)
|
2018-02-21 |
2020-09-29 |
Genentech Inc |
DOSING FOR TREATMENT WITH IL-22 Fc FUSION PROTEINS
|
|
WO2021160163A1
(en)
|
2020-02-14 |
2021-08-19 |
Evive Biotechnology (Shanghai) Ltd |
Methods for prevention or treatment of virus-induced organ injury or failure with il-22 dimer
|
|
WO2021164744A1
(en)
|
2020-02-19 |
2021-08-26 |
Evive Biotechnology (Shanghai) Ltd |
Methods for treating graft versus host disease
|